Wistar Scientists Identify a Gene Signature to Assess Cancer Risk in People
February 06, 2023 15:45 ET
|
The Wistar Institute
PHILADELPHIA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar’s Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and...
Wistar Institute HIV Researchers Win Grant to Explore Genetically Engineered Natural Killer Cells as HIV Therapy
January 19, 2023 14:44 ET
|
The Wistar Institute
PHILADELPHIA, PA, Jan. 19, 2023 (GLOBE NEWSWIRE) -- amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a...
Wistar Institute’s Maureen Murphy Named Deputy Director of the Ellen and Ronald Caplan Cancer Center
January 13, 2023 09:18 ET
|
The Wistar Institute
PHILADELPHIA, PA, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Maureen Murphy, Ph.D., has been named Deputy Director of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute. Murphy will guide the...
Collaboration Advances DNA-delivered Antibodies to Prevent COVID-19
July 07, 2022 10:00 ET
|
The Wistar Institute
Philadelphia, PA, July 07, 2022 (GLOBE NEWSWIRE) -- PHILADELPHIA — (July 7, 2022) — Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical,...
The Wistar Institute Cancer Center to be Renamed with $10 Million Gift from Caplan Family to Advance Cancer Research
March 08, 2022 13:00 ET
|
The Wistar Institute
Philadelphia, March 08, 2022 (GLOBE NEWSWIRE) -- The Wistar Institute announces that Ronald Caplan, founder and president of PMC Property Group, Inc., and his wife Ellen have donated $10 million to...
Wistar Reports New Class of Antibiotics Active Against a Wide Range of Bacteria
December 23, 2020 11:23 ET
|
The Wistar Institute
PHILADLEPHIA, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial...
DARPA and JPEO-CBRND Award $37.6M to The Wistar Institute and Collaborators at INOVIO, AstraZeneca, Penn, & Indiana University to Develop Innovative COVID-19 Treatment
December 15, 2020 11:31 ET
|
The Wistar Institute
PHILADELPHIA, Dec. 15, 2020 (GLOBE NEWSWIRE) -- A team of scientists from The Wistar Institute, INOVIO, AstraZeneca, the Perelman School of Medicine at the University of Pennsylvania, and Indiana...